Based on ratings from 4 stock analysts, the CryoPort Inc stock price is expected to increase by 51.69% in 12 months. This is calculated by using the average 12-month stock price forecast for CryoPort Inc. The lowest target is $7 and the highest is $18. Please note analyst price targets are not guaranteed and could be missed completely.
CryoPort Inc has a total of 4 Wall St Analyst ratings. There are 4 buy ratings, 0 ratings, and 0 sell ratings. Since most analysts have a buy consensus rating, the expectation is that CryoPort Inc will outperform the market. Investors shouldn't rely purely on analyst ratings; we encourage investors to also take a look at the fundamental and technical analysis in their due diligence.
These are the latest 20 analyst ratings of CYRX.
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
---|---|---|---|---|
Matthew Stanton Jefferies | Hold | $8 | Downgrade | Aug 7, 2024 |
David Saxon Needham | Buy | $11 | Maintains | Aug 7, 2024 |
Dan Leonard UBS | Neutral | $7 | Maintains | Aug 7, 2024 |
Yuan Zhi B. Riley Securities | Buy | $15 | Upgrade | Jul 31, 2024 |
David Saxon Needham | Buy | $18 | Reiterates | May 8, 2024 |
Yuan Zhi B. Riley Securities | Neutral | $19 | Downgrade | May 3, 2024 |
Matthew Stanton Jefferies | Buy | $21 | Assumes | Apr 4, 2024 |
John Sourbeer UBS | Neutral | $17 | Maintains | Mar 15, 2024 |
Jacob Johnson Stephens & Co. | Equal-Weight | $17 | Reiterates | Mar 13, 2024 |
David Saxon Needham | Buy | $18 | Maintains | Mar 13, 2024 |
David Saxon Needham | Buy | $19 | Maintains | Jan 18, 2024 |
Tejas Savant Morgan Stanley | Equal-Weight | $16 | Initiates | Aug 17, 2023 |
David Saxon Needham | Buy | $21 | Maintains | Aug 10, 2023 |
John Sourbeer UBS | Neutral | $17 | Downgrade | Jul 18, 2023 |
Jacob Johnson Stephens & Co. | Equal-Weight | $15 | Downgrade | Jul 17, 2023 |
Paul Knight Keybanc | Sector Weight | Downgrade | Jul 17, 2023 | |
David Saxon Needham | Buy | $30 | Reiterates | Jul 13, 2023 |
Jacob Johnson Stephens & Co. | Overweight | $26 | Reiterates | Jul 13, 2023 |
Richard Baldry Roth MKM | Buy | $25 | Maintains | Jul 13, 2023 |
Puneet Souda SVB Leerink | Market Perform | $10 | Downgrade | Jul 13, 2023 |
When did it IPO
N/A
Staff Count
1,100
Country
United States
Sector/Industry
Industrials/Integrated Freight & Logistics
CEO
Mr. Jerrell W. Shelton
Market Cap
$436.3M
In 2023, CYRX generated $233.3M in revenue, which was a decrease of -1.70% from the previous year. This can be seen as a signal that CYRX's business is declining, and its share price could be worth less in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2020
Revenue From 2021
Revenue From 2022
Revenue From 2023
Summary - LOS ANGELES, CA / ACCESSWIRE / August 21, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cryoport, Inc. ("Cryoport" or "the Company") (NASDAQ:CYRX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Summary - LOS ANGELES, CA / ACCESSWIRE / August 22, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cryoport, Inc. ("Cryoport" or "the Company") (NASDAQ:CYRX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Summary - LOS ANGELES, CA / ACCESSWIRE / August 19, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cryoport, Inc. ("Cryoport" or "the Company") (NASDAQ:CYRX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Summary - LOS ANGELES, CA / ACCESSWIRE / August 20, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cryoport, Inc. ("Cryoport" or "the Company") (NASDAQ:CYRX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Summary - LOS ANGELES, CA / ACCESSWIRE / August 18, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cryoport, Inc. ("Cryoport" or "the Company") (NASDAQ:CYRX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Summary - LOS ANGELES, CA / ACCESSWIRE / August 15, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cryoport, Inc. ("Cryoport" or "the Company") (NASDAQ:CYRX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.